Is Contrave FDA Approved?
DrugStatusIndex provides a clear, data-driven view of the regulatory status of medications, compounds, and related products. This page explains whether Contrave is FDA approved and how it is commonly categorized.
Overview
Contrave is a prescription weight management medication that combines naltrexone and bupropion in an extended-release tablet. It is used to support chronic weight management in adults with obesity or overweight patients with weight-related medical conditions.
FDA Status Details
Contrave is classified as FDA Approved. It received FDA approval for chronic weight management when used alongside reduced-calorie diet and increased physical activity.
Approved Use
Contrave is approved for adults with obesity (BMI 30+) or overweight adults (BMI 27+) with at least one weight-related medical condition such as high blood pressure, type 2 diabetes, or high cholesterol.
Prescription Status
Contrave is an FDA-approved branded prescription medication and should not be confused with compounded weight-loss therapies or investigational peptide treatments marketed online.
Search Another Drug or Compound
Use DrugStatusIndex to review public regulatory status information for medications, compounds, and related products.